Wird geladen...
Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment
BACKGROUND: Imatinib is a highly effective drug in up-front treatment of chronic myeloid leukemia (CML). In children impaired longitudinal growth has been reported as side effect exerted by this drug under prolonged therapy. We therefore prospectively evaluated alterations of bone biochemical marker...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
International Scientific Literature, Inc.
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3560809/ https://ncbi.nlm.nih.gov/pubmed/23197234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.883599 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|